Health TrialsbyHealthPanel

Aerobic Training on Lung Function in Fibromyalgia

ConditionsFibromyalgia (FM)Respiration Disorders
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-40
SponsorMiddle East University

About this trial

Exploring the effect of aerobic exercises on lung function, chest movement, and exercise capacity in women suffering from fibromyalgia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Well controlled fibromyalgia.

Mild restrictive lung affection.

Body mass index less than 30kg/m2.

Moderate level of physical activity.

Disqualifiers

Any chest diseases.

Musculoskeletal/ neurological limitations to exercise.

Smokers.

Pregnant.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Aerobic training

    Other intervention

    For twelve weeks, the women in the study group will participate in aerobic training on cycle ergometer. Each session will consist of 30-45 minutes of cycling at a moderate intensity, accompanied by a workout heart rate ranging from 65% to 75% of the maximal heart rate and ranging between 12 and 14 on the Borg rating of perceived exertion 20-point scale. After ten minutes of warm-up, every session will end with a brief 3-minute period of cool-down.

  • Diaphragmatic breathing exercises

    Other intervention

    From the hook-lying position, the women will receive instructions to position their hands on the rectus abdominis muscle located under the anterior chest wall. They will be advised to inhale slowly and deeply, expanding their abdomen without causing any movement in their upper chest, while simultaneously relaxing their shoulders. Slowly, the women will expel every breath. Air will be inhaled via the nose, swelling the abdomen. After the breath ceased, the women will purse her lips and exhale from his mouth with half-opened lips and a hollow belly. A single respiratory cycle consists of a three-second intake, followed by a three-second pause, and concluding with a six-second expiration phase.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Study groupActive comparator 2 interventions
Group B: Control groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Lung function

Ventilatory function parameters, including forced vital capacity and forced expiratory volume in the first second will be measured by experienced technicians at baseline and after 12 weeks in all groups using the Medgraphics pulmonary function testing system (Breezesuite Ultima PFX, Milano, Italy) in strict adherence to the guidelines outlined in the user manual.

Time frame
At baseline and 12 weeks

Secondary outcomes

1

Chest expansion

A centimeter tape measure will be used to assess chest expansion, and all measurements will be taken with the patients adopting a straight posture while standing. Two levels of chest expansion will be measured, the axillary level will be evaluated for upper chest expansion assessment, and the xyphoid level will be evaluated for lower chest expansion assessment.

Time frame
At baseline and 12 weeks
2

Exercise capacity

Cardiopulmonary exercise test will be conducted for all women at baseline and post-study based on the guidelines set by the American College of Sports Medicine to determine VO2max for each women.

Time frame
At baseline and 12 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Middle East University

Lead sponsor

Kasr El Aini Hospital

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: